Alnylam Pharmaceuticals (ALNY) EBITDA Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,807.00 |
| Dec 31, 2025 | 2,608.00 |
| Sep 30, 2025 | 4,107.00 |
| Jun 30, 2025 | -387.00 |
| Mar 31, 2025 | -5,676.00 |
| Dec 31, 2024 | 1,356.00 |
| Sep 30, 2024 | -4,063.00 |
| Jun 30, 2024 | 8,223.00 |
| Mar 31, 2024 | 3,873.00 |
| Dec 31, 2023 | 3,288.00 |
| Sep 30, 2023 | 17,449.00 |
| Jun 30, 2023 | 3,929.00 |
| Mar 31, 2023 | 6,216.00 |
| Dec 31, 2022 | 3,740.00 |
| Sep 30, 2022 | -4,616.00 |
| Jun 30, 2022 | -3,958.00 |
| Mar 31, 2022 | -604.00 |
| Dec 31, 2021 | 5,323.00 |
| Sep 30, 2021 | 9,641.00 |
| Jun 30, 2021 | 8,785.00 |
| Mar 31, 2021 | 6,979.00 |
| Dec 31, 2020 | 23,546.00 |
| Sep 30, 2020 | 9,114.00 |
| Jun 30, 2020 | 32,401.00 |
| Mar 31, 2020 | 36,661.00 |
| Dec 31, 2019 | 61,614.00 |
| Sep 30, 2019 | 1.15 Mn |
| Jun 30, 2019 | 4,588.00 |
| Mar 31, 2019 | 10,145.00 |
| Dec 31, 2018 | -62,757.00 |
| Sep 30, 2018 | -1.11 Mn |
| Jun 30, 2018 | 20,071.00 |
| Mar 31, 2018 | -7,884.00 |
| Dec 31, 2017 | 30,263.00 |
| Sep 30, 2017 | 4,075.00 |
| Jun 30, 2017 | 51,223.00 |
| Mar 31, 2017 | 101,621.00 |
| Dec 31, 2016 | 36,850.00 |
| Sep 30, 2016 | 86,655.00 |
| Jun 30, 2016 | -4,268.00 |
| Mar 31, 2016 | -132,974.00 |
| Dec 31, 2015 | -109,872.00 |
| Sep 30, 2015 | -116,226.00 |
| Jun 30, 2015 | -56,772.00 |
| Mar 31, 2015 | 271,396.00 |
| Dec 31, 2014 | 41,774.00 |
| Sep 30, 2014 | -12,199.00 |
| Jun 30, 2014 | -52,092.00 |
| Mar 31, 2014 | -294,766.00 |
| Dec 31, 2013 | 18,196.00 |
| Sep 30, 2013 | -22,552.00 |
| Jun 30, 2013 | -6,286.00 |
| Mar 31, 2013 | 3,392.00 |
| Dec 31, 2012 | -47,897.00 |
| Sep 30, 2012 | -5,214.00 |
| Jun 30, 2012 | 601.00 |
| Mar 31, 2012 | 2,684.00 |
| Dec 31, 2011 | -3,458.00 |
| Sep 30, 2011 | -2,841.00 |
| Jun 30, 2011 | -1,493.00 |
| Mar 31, 2011 | -3,170.00 |
| Dec 31, 2010 | -174.00 |
| Sep 30, 2010 | 207.00 |
| Jun 30, 2010 | 3,499.00 |